BBL
TAK icon

Beck Bode LLC’s Takeda Pharmaceutical TAK Stock Holding History

Beck Bode LLC’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-138,997
Closed -$1.8M – 249
2022
Q3 		$1.8M Buy
138,997
+44,592
+47% +$620K 0.39% 69
2022
Q2 		$1.32M Buy
94,405
+6,914
+8% +$98.7K 0.28% 77
2022
Q1 		$1.25M Buy
+87,491
New +$1.28M 0.28% 62

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Beck Bode LLC's TAK Position: Q4 2022 in Review

Beck Bode LLC sold out of Takeda Pharmaceutical (TAK) in Q4 2022, closing a stake of 138,997 shares — an estimated $1.8M sold.

Beck Bode LLC first reported a position in TAK in Q1 2022 and held it in 3 quarters. The position peaked at $1.8M in Q3 2022. 281 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

  • Beck Bode LLC reported no remaining Takeda Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Beck Bode LLC sold 138,997 Takeda Pharmaceutical shares in Q4 2022, an estimated $1.8M.
  • Beck Bode LLC first reported a position in Takeda Pharmaceutical in Q1 2022 and held it in 3 quarters.
  • Beck Bode LLC's Takeda Pharmaceutical position peaked at $1.8M in Q3 2022.
  • 281 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on Beck Bode LLC's 13F filing for Q4 2022, filed 8 Feb 2023.